Skip to content

Immunome IMNM Proceeds From Public Offering

Proceeds From Public Offering at other companies

Atlas Energy Solutions logo
Atlas Energy SolutionsAESI
$0
General Purpose Acquisition Corp.
 logo
General Purpose Acquisition Corp. GPAC
$97.11K+492%
Medline, Inc.
 logo
Medline, Inc. MDLN
$1.76B
Bicara Therapeutics logo
Bicara TherapeuticsBCAX
$332.4M
Rivian Automotive, Inc. logo
Rivian Automotive, Inc.RIVN
$1M-66.7%
NuScale Power logo
NuScale PowerSMR
$37.26M-62.6%

Other financials

Income statement

See full
Revenue--100%
Operating income-$59.3M-32.9%
Net income-$53.8M-29.3%
EPS (diluted)-$0.48+7.7%

Balance sheet

See full
Cash & equivalents$582.7M+126%
Total debt$3.7M-22.6%
Total equity$588.7M+91.7%
Total assets$619.8M+80.9%

Cash flow

See full
Operating cash flow-$58.6M-10.5%
CapEx$3.0M-18.1%
Free cash flow-$61.6M-8.7%

Valuation

See full
Market cap$2.24B+323%

Profitability

See full
Operating margin-5,947.9%-12,002pp
Net margin-5,593.8%-11,284pp
FCF margin-5,118.9%-8,601pp

Returns & leverage

See full
Return on equity-50.1%-10.8pp
Debt / equity0.0×
Current ratio21.7×+11.2×

Where this comes from

Reported directly by Immunome in its filing.

Tagged under the XBRL concept imnm:ProceedsFromPublicOffering.

The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunome's proceeds from public offering.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Immunome's proceeds from public offering?
Immunome (IMNM) reported proceeds from public offering of $0 in Q1 2026.
What does proceeds from public offering mean?
This represents the gross cash inflows received from the issuance of equity or debt securities to the public markets. It serves as a primary indicator of a company's ability to access capital markets to fund operations, research, or expansion. High proceeds often signal strong investor confidence but may also indicate significant dilution for existing shareholders.